Amjad Alkadri, MD
Vascular & Interventional Radiology · Valparaiso, INNPI 1407817513
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $48,057 of the $67,341 with a category attached, or 71.4%. Biocompatibles, Inc. accounts for 75.5% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $51,303 and has fallen 99.7% since, to $157 in 2025.
Across 89 payments — averaging $756.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biocompatibles, Inc.$51K
- AbbVie$11K
- Boston Scientific$3K
- Bard Peripheral Vascular, Inc.$2K
- Terumo Medical Corporation$442
- Merz North America, Inc.$212
- plus $718 from 8 others
What the payments were for
- Consulting fees$13,07519%
- Speaking & faculty fees$48,05771%
- Travel & lodging$3,4385%
- Food & beverage$2,7704%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biocompatibles, Inc. | 25 | $50,819 |
| AbbVie(2 entities) | 19 | $10,981 |
| Boston Scientific | 13 | $2,518 |
| Bard Peripheral Vascular, Inc. | 13 | $1,652 |
| Terumo Medical Corporation | 4 | $442 |
| Merz North America, Inc. | 3 | $212 |
| Abbott | 2 | $187 |
| Vertos Medical, Inc. | 3 | $154 |
| Covidien LP | 1 | $111 |
| Sirtex Medical Inc | 1 | $110 |
| Medtronic | 2 | $105 |
| Penumbra, Inc. | 1 | $22 |
| Venclose Inc. | 1 | $17 |
| Healthtronics Stone Solutions, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VARITHENA$52,842
- RotarexS 6 F x 135 cm$1,090
- Crosser iQ$353
- HydroPearl$215
- MetaCross$134
- mild Device Kit$118
- Emprint$111
- Perclose ProGlide suture mediated closure system$110
- SIR-Spheres Microspheres$110
How this compares
$67,341 in reported general payments places this provider in the 80th percentile of 74 vascular & interventional radiology providers in Indiana.
See all vascular & interventional radiology providers in Indiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 11 | $8,997 |
| ClopidogrelClopidogrel Bisulfate | 22 | $211 |
Paid to pharmacies, not to this prescriber.
Other vascular & interventional radiology in Valparaiso
- Paul TimpermanWest Lafayette$1.3M
- Daniel SahleinCarmel$845K
- Sabah ButtyMishawaka$275K
- Jeffrey RamkaransinghIndianapolis$274K
- Brandon MartinezFishers$226K
- Nazar GolewaleMerrillville$224K
- Kannan NatarajanIndianapolis$188K
- Katharine KrolLafayette$155K
- Matthew JohnsonIndianapolis$92K
- Ramon HalumGreenwood$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.